Upstate N Y Cancer Research & Geneva, NY - 14456

Upstate N Y Cancer Research & is categorized under Research and Development Laboratories in Geneva, NY and active since 2004.

Upstate N Y Cancer Research & was established in 2004, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Tracy Serens at the company’s single location by writing to 675 West Washington St, Geneva, New York NY 14456 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Upstate N Y Cancer Research &
Contact Person: Tracy Serens
Address: 675 West Washington St, Geneva, New York 14456
Annual Revenue (USD): $50.000 to $99.999
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Upstate N Y Cancer Research & was started in 2004 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Tracy Serens for inquiries that concern Upstate N Y Cancer Research & by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Upstate N Y Cancer Research & can be found at the coordinates 42.859032,-77.010692 as well as the street address 675 West Washington St in Geneva, New York 14456.

For its online presence, you may visit Upstate N Y Cancer Research &’s website at and engage with its social media outlets through on Twitter and on Facebook.